BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

282 related articles for article (PubMed ID: 26518678)

  • 1. Orbital tumours and tumour-like lesions: exploring the armamentarium of multiparametric imaging.
    Purohit BS; Vargas MI; Ailianou A; Merlini L; Poletti PA; Platon A; Delattre BM; Rager O; Burkhardt K; Becker M
    Insights Imaging; 2016 Feb; 7(1):43-68. PubMed ID: 26518678
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Minimal invasive biopsy of intraconal expansion by PET/CT/MRI image-guided navigation: a new method.
    Reinbacher KE; Pau M; Wallner J; Zemann W; Klein A; Gstettner C; Aigner RM; Feichtinger M
    J Craniomaxillofac Surg; 2014 Oct; 42(7):1184-9. PubMed ID: 24726395
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Imaging Findings of Pediatric Orbital Masses and Tumor Mimics.
    Joseph AK; Guerin JB; Eckel LJ; Dalvin LA; Keating GF; Liebo GB; Benson JC; Brinjikji W; Laack NN; Silvera VM
    Radiographics; 2022; 42(3):880-897. PubMed ID: 35245105
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Correlation of simultaneously acquired diffusion-weighted imaging and 2-deoxy-[18F] fluoro-2-D-glucose positron emission tomography of pulmonary lesions in a dedicated whole-body magnetic resonance/positron emission tomography system.
    Schmidt H; Brendle C; Schraml C; Martirosian P; Bezrukov I; Hetzel J; Müller M; Sauter A; Claussen CD; Pfannenberg C; Schwenzer NF
    Invest Radiol; 2013 May; 48(5):247-55. PubMed ID: 23519008
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Whole-body MRI with diffusion-weighted imaging: a valuable alternative to contrast-enhanced CT for initial staging of aggressive lymphoma.
    Balbo-Mussetto A; Cirillo S; Bruna R; Gueli A; Saviolo C; Petracchini M; Fornari A; Lario CV; Gottardi D; De Crescenzo A; Tarella C
    Clin Radiol; 2016 Mar; 71(3):271-9. PubMed ID: 26749081
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [18F]2-fluoro-2-deoxy-D-glucose positron emission tomography (FDG PET) as a diagnostic tool for neurofibromatosis 1 (NF1) associated malignant peripheral nerve sheath tumours (MPNSTs): a long-term clinical study.
    Ferner RE; Golding JF; Smith M; Calonje E; Jan W; Sanjayanathan V; O'Doherty M
    Ann Oncol; 2008 Feb; 19(2):390-4. PubMed ID: 17932395
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Combined positron emission tomography/computed tomography (PET/CT) for imaging of orbital tumours and tumours extending into the orbit.
    Klingenstein A; Mueller-Lisse GU; Haug AR; Garip-Kuebler A; Miller CV; Hintschich CR
    Br J Ophthalmol; 2016 Oct; 100(10):1403-8. PubMed ID: 26769673
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Whole-Body MRI with Diffusion-Weighted Imaging in Bone Metastases: A Narrative Review.
    Stecco A; Trisoglio A; Soligo E; Berardo S; Sukhovei L; Carriero A
    Diagnostics (Basel); 2018 Jul; 8(3):. PubMed ID: 29987207
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Assessment of metastatic colorectal cancer with hybrid imaging: comparison of reading performance using different combinations of anatomical and functional imaging techniques in PET/MRI and PET/CT in a short case series.
    Brendle C; Schwenzer NF; Rempp H; Schmidt H; Pfannenberg C; la Fougère C; Nikolaou K; Schraml C
    Eur J Nucl Med Mol Imaging; 2016 Jan; 43(1):123-132. PubMed ID: 26224536
    [TBL] [Abstract][Full Text] [Related]  

  • 10. 18F-Fluorodeoxyglucose Positron Emission Tomography/Magnetic Resonance in Lymphoma: Comparison With 18F-Fluorodeoxyglucose Positron Emission Tomography/Computed Tomography and With the Addition of Magnetic Resonance Diffusion-Weighted Imaging.
    Giraudo C; Raderer M; Karanikas G; Weber M; Kiesewetter B; Dolak W; Simonitsch-Klupp I; Mayerhoefer ME
    Invest Radiol; 2016 Mar; 51(3):163-9. PubMed ID: 26784400
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Orbital masses: CT and MRI of common vascular lesions, benign tumors, and malignancies.
    Khan SN; Sepahdari AR
    Saudi J Ophthalmol; 2012 Oct; 26(4):373-83. PubMed ID: 23961022
    [TBL] [Abstract][Full Text] [Related]  

  • 12. More advantages in detecting bone and soft tissue metastases from prostate cancer using
    Pianou NK; Stavrou PZ; Vlontzou E; Rondogianni P; Exarhos DN; Datseris IE
    Hell J Nucl Med; 2019; 22(1):6-9. PubMed ID: 30843003
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A Comprehensive Comparison of CT, MRI, Positron Emission Tomography or Positron Emission Tomography/CT, and Diffusion Weighted Imaging-MRI for Detecting the Lymph Nodes Metastases in Patients with Cervical Cancer: A Meta-Analysis Based on 67 Studies.
    Liu B; Gao S; Li S
    Gynecol Obstet Invest; 2017; 82(3):209-222. PubMed ID: 28183074
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Masses of developmental and genetic origin affecting the paediatric craniofacial skeleton.
    Stefanelli S; Mundada P; Rougemont AL; Lenoir V; Scolozzi P; Merlini L; Becker M
    Insights Imaging; 2018 Aug; 9(4):571-589. PubMed ID: 29766474
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Magnetic resonance imaging in the analysis of pediatric orbital tumors: utility of diffusion-weighted imaging.
    Lope LA; Hutcheson KA; Khademian ZP
    J AAPOS; 2010 Jun; 14(3):257-62. PubMed ID: 20603060
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Diagnostic value of diffusion-weighted magnetic resonance imaging (DWI) compared to FDG PET/CT for whole-body breast cancer staging.
    Heusner TA; Kuemmel S; Koeninger A; Hamami ME; Hahn S; Quinsten A; Bockisch A; Forsting M; Lauenstein T; Antoch G; Stahl A
    Eur J Nucl Med Mol Imaging; 2010 Jun; 37(6):1077-86. PubMed ID: 20204355
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Economic Benefits and Diagnostic Quality of Diffusion-Weighted Magnetic Resonance Imaging for Primary Lung Cancer.
    Usuda K; Funazaki A; Maeda R; Sekimura A; Motono N; Matoba M; Uramoto H
    Ann Thorac Cardiovasc Surg; 2017 Dec; 23(6):275-280. PubMed ID: 28978865
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Evaluation of Diffusion-Weighted Magnetic Resonance Imaging for Follow-up and Treatment Response Assessment of Lymphoma: Results of an 18F-FDG-PET/CT-Controlled Prospective Study in 64 Patients.
    Mayerhoefer ME; Karanikas G; Kletter K; Prosch H; Kiesewetter B; Skrabs C; Porpaczy E; Weber M; Knogler T; Sillaber C; Jaeger U; Simonitsch-Klupp I; Ubl P; Müllauer L; Dolak W; Lukas J; Raderer M
    Clin Cancer Res; 2015 Jun; 21(11):2506-13. PubMed ID: 25733598
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Impact of 3T multiparametric MRI and FDG-PET-CT in the evaluation of occult primary cancer with cervical node metastasis.
    Gődény M; Lengyel Z; Polony G; Nagy ZT; Léránt G; Zámbó O; Remenár É; Tamás L; Kásler M
    Cancer Imaging; 2016 Nov; 16(1):38. PubMed ID: 27814768
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Evaluation of (18)fluorodeoxyglucose positron emission tomography ((18)FDG PET) in the detection of malignant peripheral nerve sheath tumours arising from within plexiform neurofibromas in neurofibromatosis 1.
    Ferner RE; Lucas JD; O'Doherty MJ; Hughes RA; Smith MA; Cronin BF; Bingham J
    J Neurol Neurosurg Psychiatry; 2000 Mar; 68(3):353-7. PubMed ID: 10675220
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.